Cover Image
市場調查報告書

臨床試驗資材市場分析·預測:第一階段·第二階段·第三階段

Clinical Trial Supplies Market Analysis By Phase (Phase I, Phase II, Phase III), By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management), By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 544784
出版日期 內容資訊 英文 95 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
臨床試驗資材市場分析·預測:第一階段·第二階段·第三階段 Clinical Trial Supplies Market Analysis By Phase (Phase I, Phase II, Phase III), By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management), By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2014 - 2025
出版日期: 2017年07月24日 內容資訊: 英文 95 Pages
簡介

本報告提供全球臨床試驗資材的市場調查,提供市場定義和概要,市場成長的各種影響因素分析,各階段·產品&服務區分·最終用途·疾病區分·地區/主要國家趨勢與市場規模的變化與預測,競爭環境,並彙整主要企業的簡介等資訊。

第1章 調查手法·調查範圍

第2章 摘要整理

第3章 市場可變因素·趨勢·展望

  • 市場區隔·市場展望
  • 市場促進因素分析
  • 普及·成長預測製圖
  • SWOT分析
  • 波特的產業分析

第4章 市場估計·趨勢分析:不同階段

  • 市場佔有率實際成果·預測
  • 第一階段
  • 第二階段
  • 第三階段
  • 其他

第5章 市場估計·趨勢分析:產品與服務別

  • 市場佔有率實際成果·預測
  • 製造
  • 貯存·流通
  • 供應鏈管理
    • 低溫運輸
    • 非低溫運輸

第6章 市場估計·趨勢分析:最終用途別

  • 市場佔有率實際成果·預測
  • 醫藥品
  • 生物製藥
  • 醫療設備
  • 其他

第7章 市場估計·趨勢分析:各疾病種類

  • 市場佔有率實際成果·預測
  • 癌症
  • CNS
  • 心血管疾病
  • 感染疾病
  • 代謝性疾病
  • 其他

第8章 市場估計·趨勢分析:各地區

  • 市場佔有率實際成果·預測
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
  • 亞太地區
    • 日本
    • 中國
  • 南美
    • 巴西
    • 墨西哥
  • 中東·非洲
    • 南非
    • 沙烏地阿拉伯

第9章 競爭環境

  • 策略性架構
  • 企業簡介
目錄
Product Code: GVR-1-68038-514-4

The global clinical trial supplies market is expected to reach USD 3.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness growth at 7.3% CAGR owing to Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are the primary driver of the industry. Furthermore, geographic expansion and development of Information Technology (IT) to facilitate higher integration and smooth performance of activities are other vitally impacting parameters. Over the next eight years, the clinical trials and pharmaceutical industry is anticipated to continue steady growth, thereby promoting the high requirement of clinical trial supplies.

U.S and Canada are home to majority of clinical trials which are conducted in this region. No language barrier is one of the major factor for the preference of this region for majority of clinical trials, as English language is widely spoken in this region. Major CRO's and biopharmaceutical companies have their hub in this region and with advancement in technology the demand for efficient supplies are increasing and the region is expected to dominate the clinical trial supplies market over the forecast period.

Further Key Findings From the Study Suggest:

On the basis of clinical phase, the market is anticipated to be dominated by Phase III in 2025. The presence of large number of molecule estimated to reach Phase III by 2020 is the primary factor responsible for this prediction.

By services, storage and distribution is anticipated to witness the fastest growth at a CAGR of over 7.0%.

Key end-users of this industry are pharmaceuticals, and biologics. Biologics are expected to witness fastest growth owing to the increasing research in the field of genetics and biotechnology such as development of nanoparticle based drug delivery systems.

In terms of therapeutic use or clinical indication, oncology dominates the market. The highest research activity as of 2016 is being performed for this indication, which in turn is expected to drive the market.

Few of the industry players include Movianto GmbH, Thermo Fischer Scientific, Sharp Packaging Services, Catalent Pharma Solution, Biocair International Ltd., PCI Services, Almac Group Ltd, and Patheon Inc. Other players present in the market space include Clinigen Group Plc, Merck Serono, and Chimerix.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
    • 1.1.1. Purchased Database
    • 1.1.2. GVR's Internal Database
  • 1.2. Data Analysis
  • 1.3. Market Formulation & Validation
  • 1.4. Approaches for Market Estimation

Chapter 2. Executive Summary

  • 2.1. Market Snapshot

Chapter 3. Clinical Trial Supplies Market Variables, Trends & Scope

  • 3.1. Market Segmentation & Scope
  • 3.2. Market Driver Analysis
  • 3.3. Penetration & Growth Prospect Mapping
  • 3.4. SWOT Analysis, by Factor
    • 3.4.1. Political
    • 3.4.2. Economic
    • 3.4.3. Technological
  • 3.5. Industry Analysis - Porter's

Chapter 4. Clinical Trial Supplies: Clinical Phase Estimates & Trend Analysis

  • 4.1. Clinical Trial Supplies Market Share, 2016 & 2025
  • 4.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following clinical phase:
    • 4.2.1. Phase I
      • 4.2.1.1. Phase I market estimates and forecasts, 2014 to 2025
    • 4.2.2. Phase II
      • 4.2.2.1. Phase II market estimates and forecasts, 2014 to 2025
    • 4.2.3. Phase III
      • 4.2.3.1. Phase III market estimates and forecasts, 2014 to 2025
    • 4.2.4. Others
      • 4.2.4.1. Other phases market estimates and forecasts, 2014 to 2025

Chapter 5. Clinical Trial Supplies: Product & Services Estimates & Trend Analysis

  • 5.1. Product & Services Market Share, 2016 & 2025
  • 5.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following product & services:
    • 5.2.1. Manufacturing
      • 5.2.1.1. Manufacturing market estimates and forecasts, 2014 to 2025
    • 5.2.2. Storage & Distribution
      • 5.2.2.1. Storage & distribution market estimates and forecasts, 2014 to 2025
    • 5.2.3. Supply chain management
      • 5.2.3.1. Supply chain management market estimates and forecasts, 2014 to 2025
      • 5.2.3.2. Cold chain distribution
      • 5.2.3.2.1. Cold chain distribution market estimates and forecasts, 2014 to 2025
      • 5.2.3.3. Non-cold chain distribution
      • 5.2.3.3.1. Non-cold chain distribution market estimates and forecasts, 2014 to 2025

Chapter 6. Clinical Trial Supplies: End-Use Estimates & Trend Analysis

  • 6.1. Clinical Trial Supplies Market Share, 2016 & 2025
  • 6.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following end-users:
    • 6.2.1. Pharmaceuticals
      • 6.2.1.1. Pharmaceuticals market estimates and forecasts, 2014 to 2025
    • 6.2.2. Biologics
      • 6.2.2.1. Biologics market estimates and forecasts, 2014 to 2025
    • 6.2.3. Medical Devices
      • 6.2.3.1. Medical Devices market estimates and forecasts, 2014 to 2025
    • 6.2.4. Others
      • 6.2.4.1. Others market estimates and forecasts, 2014 to 2025

Chapter 7. Clinical Trial Supplies: Therapeutic Use Estimates & Trend Analysis

  • 7.1. Clinical Trial Supplies Market Share, 2016 & 2025
  • 7.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following therapeutic use:
    • 7.2.1. Oncology
      • 7.2.1.1. Oncology market estimates and forecasts, 2014 to 2025
    • 7.2.2. CNS
      • 7.2.2.1. CNS market estimates and forecasts, 2014 to 2025
    • 7.2.3. Cardiovascular
      • 7.2.3.1. Cardiovascular market estimates and forecasts, 2014 to 2025
    • 7.2.4. Infectious disease
      • 7.2.4.1. Infectious Disease market estimates and forecasts, 2014 to 2025
    • 7.2.5. Metabolic disorders
      • 7.2.5.1. Metabolic disorders market estimates and forecasts, 2014 to 2025
    • 7.2.6. Others
      • 7.2.6.1. Other therapeutic areas market estimates and forecasts, 2014 to 2025

Chapter 8. Clinical Trial Supplies: Regional Estimates & Trend Analysis

  • 8.1. Clinical Trial Supplies Regional Movement Analysis & Market Share, 2016 & 2025
  • 8.2. North America
    • 8.2.1. U.S.
      • 8.2.1.1. U.S. revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
      • 8.2.1.2. U.S. revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
      • 8.2.1.3. U.S. revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
      • 8.2.1.4. U.S. revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
    • 8.2.2. Canada
      • 8.2.2.1. Canada revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
      • 8.2.2.2. Canada revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
      • 8.2.2.3. Canada revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
      • 8.2.2.4. Canada revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
  • 8.3. Europe
    • 8.3.1. UK
      • 8.3.1.1. UK revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
      • 8.3.1.2. UK revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
      • 8.3.1.3. UK revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
      • 8.3.1.4. UK revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Germany revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
      • 8.3.2.2. Germany revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
      • 8.3.2.3. Germany revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
      • 8.3.2.4. Germany revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Japan
      • 8.4.1.1. Japan revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
      • 8.4.1.2. Japan revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
      • 8.4.1.3. Japan revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
      • 8.4.1.4. Japan revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
      • 8.4.2.2. China revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
      • 8.4.2.3. China revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
      • 8.4.2.4. China revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Brazil
      • 8.5.1.1. Brazil revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
      • 8.5.1.2. Brazil revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
      • 8.5.1.3. Brazil revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
      • 8.5.1.4. Brazil revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
    • 8.5.2. Mexico
      • 8.5.2.1. Mexico revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
      • 8.5.2.2. Mexico revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
      • 8.5.2.3. Mexico revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
      • 8.5.2.4. Mexico revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
  • 8.6. MEA
    • 8.6.1. South Africa
      • 8.6.1.1. South Africa revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
      • 8.6.1.2. South Africa revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
      • 8.6.1.3. South Africa revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
      • 8.6.1.4. South Africa revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia revenue estimates and forecasts by, clinical phase, 2014 - 2025 (USD Million)
      • 8.6.2.2. Saudi Arabia revenue estimates and forecasts by, product & services, 2014 - 2025 (USD Million)
      • 8.6.2.3. Saudi Arabia revenue estimates and forecasts by, end-use, 2014 - 2025 (USD Million)
      • 8.6.2.4. Saudi Arabia revenue estimates and forecasts by, therapeutic use, 2014 - 2025 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Strategy Framework
  • 9.2. Company Profiles
    • 9.2.1. Almac Group Ltd.
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Biocair International Ltd.
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Product Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Catalent Pharma Solutions
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Product Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. KLIFO A/S
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Product Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Movianto GmbH
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Product Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. PCI Services
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Product Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Patheon, Inc.
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Product Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. PAREXEL International Corporation
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Product Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. Sharp Packaging Services
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Product Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Thermo Fischer Scientific, Inc.
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Product Benchmarking
      • 9.2.10.4. Strategic Initiatives

List of Tables

  • 1. North America clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
  • 2. North America clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 3. North America clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 4. North America clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 5. North America clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 6. U.S. clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
  • 7. U.S. clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 8. U.S. clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 9. U.S. clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 10. U.S. clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 11. Canada clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
  • 12. Canada clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 13. Canada clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 14. Canada clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 15. Canada clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 16. Europe clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
  • 17. Europe clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 18. Europe clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 19. Europe clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 20. Europe clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 21. UK clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
  • 22. UK clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 23. UK clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 24. UK clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 25. UK clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 26. Germany clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
  • 27. Germany clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 28. Germany clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 29. Germany clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 30. Germany clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 31. Germany clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
  • 32. Asia Pacific clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 33. Asia Pacific clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 34. Asia Pacific clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 35. Asia Pacific clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 36. Asia Pacific clinical trials supplies market, by clinical phases, 2014 - 2025 (USD Million)
  • 37. Japan clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 38. Japan clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 39. Japan clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 40. Japan clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 41. China clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 42. China clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 43. China clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 44. China clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 45. Latin America clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 46. Latin America clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 47. Latin America clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 48. Latin America clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 49. Brazil clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 50. Brazil clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 51. Brazil clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 52. Brazil clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 53. Mexico clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 54. Mexico clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 55. Mexico clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 56. Mexico clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 57. MEA clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 58. MEA clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 59. MEA clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 60. MEA clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 61. South Africa clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 62. South Africa clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 63. South Africa clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 64. South Africa clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)
  • 65. Saudi Arabia clinical trials supplies market, by product and services, 2014 - 2025 (USD Million)
  • 66. Saudi Arabia clinical trials supply chain management market, by type, 2014 - 2025 (USD Million)
  • 67. Saudi Arabia clinical trials supplies market, by end-use, 2014 - 2025 (USD Million)
  • 68. Saudi Arabia clinical trials supplies market, by therapeutics use, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market summary (Figures in USD Million, 2016)
  • FIG. 8 Market trends & outlook
  • FIG. 9 Clinical trial supplies market: Market segmentation
  • FIG. 10 Clinical trial supplies market revenue, (USD Million), 2014 - 2025
  • FIG. 11 Key Opportunities Prioritized
  • FIG. 12 Clinical trial supplies: Porter's analysis
  • FIG. 13 Clinical trial supplies: PESTEL analysis
  • FIG. 14 Clinical trial supplies market phase outlook key takeaways
  • FIG. 15 Clinical trial supplies market: Phase movement analysis
  • FIG. 16 Phase I market, 2014 - 2025 (USD Million)
  • FIG. 17 Phase II market, 2014 - 2025 (USD Million)
  • FIG. 18 Phase III market, 2014 - 2025 (USD Million)
  • FIG. 19 Others market, 2014 - 2025 (USD Million)
  • FIG. 20 Clinical trial supplies market product/service outlook key takeaways
  • FIG. 21 Clinical trial supplies market: Product/Service movement analysis
  • FIG. 22 Manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 23 Storage & distribution market, 2014 - 2025 (USD Million)
  • FIG. 24 Cold chain based storage & distribution market, 2014 - 2025 (USD Million)
  • FIG. 25 Non-cold chain based storage & distribution market, 2014 - 2025 (USD Million)
  • FIG. 26 Supply chain management market, 2014 - 2025 (USD Million)
  • FIG. 27 Clinical trial supplies market end-use outlook key takeaways
  • FIG. 28 Clinical trial supplies market: End-use movement analysis
  • FIG. 29 Pharmaceuticals market, 2014 - 2025 (USD Million)
  • FIG. 30 Biologics market, 2014 - 2025 (USD Million)
  • FIG. 31 Medical device market, 2014 - 2025 (USD Million)
  • FIG. 32 Other end-use market, 2014 - 2025 (USD Million)
  • FIG. 33 Clinical trial supplies market therapeutic use outlook key takeaways
  • FIG. 34 Clinical trial supplies market: Therapeutic use movement analysis
  • FIG. 35 Oncology market, 2014 - 2025 (USD Million)
  • FIG. 36 CNS market, 2014 - 2025 (USD Million)
  • FIG. 37 Cardiovascular market, 2014 - 2025 (USD Million)
  • FIG. 38 Infectious disease market, 2014 - 2025 (USD Million)
  • FIG. 39 Metabolic disorders market, 2014 - 2025 (USD Million)
  • FIG. 40 Other therapeutic use market, 2014 - 2025 (USD Million)
  • FIG. 41 Regional market place: Key takeaways
  • FIG. 42 North America clinical trial supplies market, 2013 - 2024 (USD Million)
  • FIG. 43 U.S. clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 44 Canada clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 45 Europe clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 46 UK clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 47 Germany clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 48 Asia Pacific clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 49 Japan clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 50 China clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 51 Latin America clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 52 Brazil clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 53 Mexico clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 54 MEA clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 55 South Africa clinical trial supplies market, 2014 - 2025 (USD Million)
  • FIG. 56 Saudi Arabia clinical trial supplies market, 2014 - 2025 (USD Million)
Back to Top